BioCryst Pharmaceuticals, Inc. (BCRX) by event type
BCRX moves most on coverage initiations — a median of +0.41% at 30 minutes across 10 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the BCRX overview →
How BCRX reacts across 3 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations 466 of 2,283 | 10 | +0.41% | 80% | +0.12% |
| Rating reiterations 3,070 of 3,522 | 81 | -0.27% | 41% | -0.39% |
| Price-target raises 1,604 of 1,790 | 18 | -0.23% | 44% | +1.84% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 3 further classes were observed with fewer than 10 measured events and are not published.
That’s how BCRX usually reacts — get an email when it moves on news →Every name measured for these event types: Coverage initiations → · Rating reiterations → · Price-target raises → · BCRX overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| CORIUM INTL (CORI) | 380 | 0.00% | 46% |
| PROTEON THERAPEUTICS (PRTO) | 380 | 0.00% | 39% |
| Constellation Pharmaceuticals, Inc (CNST) | 379 | 0.00% | 44% |
| CONTRAVIR PHARMACEUTICALS INC (CTRV) | 379 | -0.51% | 36% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.